Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

Similar articles for PubMed (Select 11147810)

1.

Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.

Ohana G, Bar-Yehuda S, Barer F, Fishman P.

J Cell Physiol. 2001 Jan;186(1):19-23. Review.

PMID:
11147810
2.

Adenosine acts as a chemoprotective agent by stimulating G-CSF production: a role for A1 and A3 adenosine receptors.

Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G.

J Cell Physiol. 2000 Jun;183(3):393-8.

PMID:
10797314
3.

Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor.

Fishman P, Bar-Yehuda S, Ohana G, Pathak S, Wasserman L, Barer F, Multani AS.

Eur J Cancer. 2000 Jul;36(11):1452-8.

PMID:
10899660
4.

The A3 adenosine receptor as a new target for cancer therapy and chemoprotection.

Fishman P, Bar-Yehuda S, Barer F, Madi L, Multani AS, Pathak S.

Exp Cell Res. 2001 Oct 1;269(2):230-6.

PMID:
11570815
5.

Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.

Morello S, Petrella A, Festa M, Popolo A, Monaco M, Vuttariello E, Chiappetta G, Parente L, Pinto A.

Cancer Biol Ther. 2008 Feb;7(2):278-84. Epub 2007 Nov 14.

6.

A glance at adenosine receptors: novel target for antitumor therapy.

Merighi S, Mirandola P, Varani K, Gessi S, Leung E, Baraldi PG, Tabrizi MA, Borea PA.

Pharmacol Ther. 2003 Oct;100(1):31-48. Review.

PMID:
14550503
7.

Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.

Abbracchio MP, Cattabeni F.

Ann N Y Acad Sci. 1999;890:79-92.

PMID:
10668415
8.

Resistance of muscle to tumor metastases: a role for a3 adenosine receptor agonists.

Bar-Yehuda S, Barer F, Volfsson L, Fishman P.

Neoplasia. 2001 Mar-Apr;3(2):125-31.

9.

Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.

Fishman P, Bar-Yehuda S, Ardon E, Rath-Wolfson L, Barrer F, Ochaion A, Madi L.

Anticancer Res. 2003 May-Jun;23(3A):2077-83.

PMID:
12894581
10.

Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.

Hoskin DW, Butler JJ, Drapeau D, Haeryfar SM, Blay J.

Int J Cancer. 2002 May 20;99(3):386-95.

PMID:
11992407
11.

A3 adenosine receptor as a target for cancer therapy.

Fishman P, Bar-Yehuda S, Madi L, Cohn I.

Anticancer Drugs. 2002 Jun;13(5):437-43. Review.

PMID:
12045454
12.

Adenosine receptors and cancer.

Fishman P, Bar-Yehuda S, Synowitz M, Powell JD, Klotz KN, Gessi S, Borea PA.

Handb Exp Pharmacol. 2009;(193):399-441. doi: 10.1007/978-3-540-89615-9_14. Review.

13.

A3 adenosine receptor agonist potentiates natural killer cell activity.

Harish A, Hohana G, Fishman P, Arnon O, Bar-Yehuda S.

Int J Oncol. 2003 Oct;23(4):1245-9.

PMID:
12964011
14.
15.

Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells.

Merighi S, Mirandola P, Milani D, Varani K, Gessi S, Klotz KN, Leung E, Baraldi PG, Borea PA.

J Invest Dermatol. 2002 Oct;119(4):923-33.

16.

Activation of the A3 adenosine receptor affects cell cycle progression and cell growth.

Brambilla R, Cattabeni F, Ceruti S, Barbieri D, Franceschi C, Kim YC, Jacobson KA, Klotz KN, Lohse MJ, Abbracchio MP.

Naunyn Schmiedebergs Arch Pharmacol. 2000 Mar;361(3):225-34.

PMID:
10731034
17.

Functional expression of adenosine A2A and A3 receptors in the mouse dendritic cell line XS-106.

Dickenson JM, Reeder S, Rees B, Alexander S, Kendall D.

Eur J Pharmacol. 2003 Aug 1;474(1):43-51.

PMID:
12909194
18.

Knockout of A3 adenosine receptors reduces mouse intraocular pressure.

Avila MY, Stone RA, Civan MM.

Invest Ophthalmol Vis Sci. 2002 Sep;43(9):3021-6.

PMID:
12202525
19.

Adenosine-induced apoptosis in glomerular mesangial cells.

Zhao Z, Kapoian T, Shepard M, Lianos EA.

Kidney Int. 2002 Apr;61(4):1276-85.

20.

A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.

Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, Fishman P.

J Biol Chem. 2003 Oct 24;278(43):42121-30. Epub 2003 Jul 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk